Claire E. O'Hanlon is a doctoral candidate at the Pardee RAND Graduate School and an assistant policy analyst at the RAND Corporation. Her current work focuses on health care quality improvement, end-of-life care and advance care planning, and evidence-based medicine.
O'Hanlon also currently serves as the On-the-Job Training Broker for RAND Health as a liaison helping fellow students find research projects. She is currently writing a dissertation on the effects of health care industry consolidation.
Before Pardee RAND, O'Hanlon was a research assistant at University of Chicago Medicine, where she worked on validating prognostic models. During this time, she was a business development intern at Knopp Biosciences, a biotechnology start-up, where she developed a pharmacoeconomic model of Parkinson's disease. Prior to her career in health policy and outcomes research, she was a laboratory technician at Duquesne University, where she designed drug delivery agents.
O'Hanlon holds a Master of Public Policy from the University of Chicago Harris School, a certificate in Health Administration and Policy from the University of Chicago, and a B.S. in engineering from Harvey Mudd College.
Singer AE, Goebel JR, Kim YS, Dy SM, Ahluwalia SC, Clifford M, Dzeng E, O'Hanlon C, Motala A, Walling AM, Goldberg J, Meeker D, Ochotorena C, Shanman R, Cui M, Lorenz KA, "Populations and Interventions for Palliative and End-of-Life Care: A Systematic Review," Journal of Palliative Care Medicine (forthcoming)
Linnemayr SG, O'Hanlon CE, Uscher-Pines L, Van Abel K, Nelson C, "Using Insights from Behavioral Economics to Strengthen Disaster Preparedness and Response," Disaster Medicine and Public Health Preparedness (forthcoming)
O'Hanlon CE, Amede KG, O'Hear MR, Janjic JM, "NIR-Labeled Perfluoropolyether Nanoemulsions for Drug Delivery and Imaging," Journal of Fluorine Chemistry, 137:27-33, 2012